Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$32.22 - $44.59 $3.71 Million - $5.13 Million
-115,072 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$37.26 - $67.74 $7.57 Million - $13.8 Million
-203,086 Reduced 63.83%
115,072 $4.63 Million
Q4 2020

Feb 16, 2021

SELL
$45.01 - $65.47 $23.5 Million - $34.1 Million
-521,346 Reduced 62.1%
318,158 $18.8 Million
Q3 2020

Nov 16, 2020

BUY
$35.79 - $48.81 $21.1 Million - $28.8 Million
589,563 Added 235.88%
839,504 $40.8 Million
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $810,850 - $1.57 Million
32,499 Added 14.95%
249,941 $12.1 Million
Q1 2020

May 15, 2020

BUY
$16.96 - $34.16 $3.69 Million - $7.43 Million
217,442 New
217,442 $6.04 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.2B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.